Prolyl oligopeptidase is a cytosolic serine peptidase that hydrolyzes proline-containing peptides at the carboxy terminus. This peptidase has been associated with schizophrenia, bipolar affective disorder, and related neuropsychiatric disorders, and therefore may have important clinical implications. Among the strategies used to find novel prolyl oligopeptidase inhibitors, traditional Chinese medicinal plants provide a rich source of unexplored compounds. We used (19)F NMR spectroscopy to search for new prolyl oligopeptidase inhibitors in a library of traditional Chinese medicine plant extracts. Several extracts were identified as powerful inhibitors of this peptidase. The alkaloid berberine was the prolyl oligopeptidase inhibitory molecule isolated from Rhizoma coptidis extract. Berberine inhibited prolyl oligopeptidase in a dose-dependent manner. As berberine is a natural compound that has been safely administered to humans, it opens up new perspectives for the treatment of neuropsychiatric diseases. The results described herein suggest that the initiation of clinical trials in patients with schizophrenia, bipolar affective disorder, or related diseases in which cognitive capabilities are affected should be undertaken with either the extract or pure BBR.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cmdc.200600303 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identifying candidate genes for sugar accumulation in sugarcane: an integrative approach.
BMC Genomics
December 2024
Institute of Biology (IB), State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Background: Elucidating the intricacies of the sugarcane genome is essential for breeding superior cultivars. This economically important crop originates from hybridizations of highly polyploid Saccharum species. However, the large size (10 Gb), high degree of polyploidy, and aneuploidy of the sugarcane genome pose significant challenges to complete genome sequencing, assembly, and annotation.
View Article and Find Full Text PDFPostproline Cleaving Enzymes also Show Specificity to Reduced Cysteine.
Anal Chem
December 2024
Institute of Microbiology of the Czech Academy of Sciences, BioCeV, Videnska 1083, Prague 4 14220, Czechia.
In proteomics, postproline cleaving enzymes (PPCEs), such as prolyl endopeptidase (PEP) and neprosin, complement proteolytic tools because proline is a stop site for many proteases. But while aiming at using PEP in online proteolysis, we found that this enzyme also displayed specificity to reduced cysteine. By LC-MS/MS, we systematically analyzed PEP sources and conditions that could affect this cleavage preference.
View Article and Find Full Text PDFStructural adaptations for carboxypeptidase activity in putative S9 acylaminoacyl peptidase from Bacillus subtilis.
Int J Biol Macromol
December 2024
Beamline Development and Application Section, Bhabha Atomic Research Centre, Mumbai 400085, Maharashtra, India. Electronic address:
Article Synopsis
- * A study on S9 peptidase from Bacillus subtilis (S9bs) has confirmed its carboxypeptidase activity, which was previously unclear, highlighting key structural elements essential for this function.
- * The research also revealed S9bs forms stable tetramers and identified its molecular arrangement, providing insights that could aid in therapeutic and drug design related to S9 family enzymes.
Synthesis of 2,4-Bis(trifluoromethyl)benzaldehyde Hybrid Thiosemicarbazones as Prolyl Oligopeptidase Inhibitors for Neurodegenerative Disorders and their In-silico Analysis.
Curr Med Chem
October 2024
Institute of Chemical Sciences, Bahauddin Zakariya University, Multan-60800, Pakistan.
Introduction: Prolyl-specific oligopeptidase (POP), one of the brain's highly expressed enzymes, is an important target for the therapy of central nervous system disorders, notably autism spectrum disorder, schizophrenia, Parkinson's, Alzheimer's disease, and dementia.
Method: The current study was designed to investigate 2,4-bis(trifluoromethyl) benzaldehyde- based thiosemicarbazones as POP inhibitors to treat the above-mentioned disorders. A variety of techniques, such as nuclear magnetic resonance (NMR), mass spectrometry (MS), and Fourier-transform infrared spectroscopy (FTIR), were used for the structural confirmation of synthesized compounds.
Novel mutation in XPNPEP3 in a patient with heart failure without nephronophthisis-like nephropathy (NPHPL1): case report and literature review.
BMC Pediatr
October 2024
Department of Cardiology, Beijing Children's Hospital, Capital Medical University, National Centre for Children's Health, Beijing, China.
BACKGROUND X-PROLYL AMINOPEPTIDASE 3: (XPNPEP3) mutations are known to cause nephronophthisis-like nephropathy-1 (NPHPL1), a rare autosomal-recessive kidney disease characterized by progressive kidney failure and cystic kidney disease in childhood. The full phenotypic spectrum associated with mutations in XPNPEP3 is not fully elucidated. CASE PRESENTATION: A 13-year-old Chinese female patient with intellectual disability presented with a 2-year history of convulsions and fatigue, with a recent episode of swelling, breathlessness, and nocturnal dyspnea lasting 10 days.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!